1. A Systematic Review of Neurocognitive Effects of Subanesthetic Doses of Intravenous Ketamine in Major Depressive Disorder, Post-Traumatic Stress Disorder, and Healthy Population

   • Paulo R. Shiroma
   • Mario Renato Velit-Salazar
   • Yelena Vorobyov

   Systematic Review 07 June 2022 Pages: 549 - 566

   

2. Pharmacological Anti-Remodelling Effects of Disease-Modifying Drugs in Heart Failure with Reduced Ejection Fraction

   • Michele Correale
   • Pietro Mazzeo
   • Natale Daniele Brunetti

   Review Article 20 June 2022 Pages: 567 - 579

   

3. Guillain–Barré Syndrome Associated with COVID-19 Vaccines: A Perspective From Spontaneous Report Data

   • Marina Atzenhoffer
   • Marine Auffret
   • Thierry Vial

   Original Research Article 09 June 2022 Pages: 581 - 592

   

4. Thromboembolic Events While Taking Direct Oral Anticoagulants: An Analysis of Post-market WHO Database Reports from 2012 to 2020

   • Darko Mitrovic
   • Wouter Emmens
   • Patricia van den Bemt

   Original Research Article 08 June 2022 Pages: 593 - 598

   

5. Cost-Effectiveness of First-Line Nivolumab Plus Ipilimumab Combination Therapy in Advanced Non-Small-Cell Lung Cancer in Japan

   • Xiuting Mo
   • Kensuke Moriwaki
   • Kojiro Shimozuma

   Original Research Article 08 June 2022 Pages: 599 - 609

   

6. Temporal Trends in Grade 3/4 Adverse Events and Associated Costs of Nivolumab Plus Cabozantinib Versus Sunitinib for Previously Untreated Advanced Renal Cell Carcinoma

   • Daniel M. Geynisman
   • Mauricio Burotto
   • Bradley McGregor

   Original Research Article Open access 13 June 2022 Pages: 611 - 622

   

7. Pharmacokinetics and Safety of Erenumab after a Single Subcutaneous Injection Dose in Healthy Chinese Subjects

   • Qi Shen
   • Ying Jin
   • Zhenlei Wang

   Original Research Article 21 June 2022 Pages: 623 - 630